Single-Use Chromatography Membrane Market Report 2026

The single-use chromatography membrane market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to expansion of single-use biomanufacturing practices, increasing biologics production volumes, rising demand for faster purification cycles, wider adoption of membrane-based separation technologies, reduced reliance on reusable columns.

The single-use chromatography membrane market size is expected to see rapid growth in the next few years. It will grow to $2.7 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing investments in disposable bioprocess solutions, rising demand for flexible manufacturing platforms, expansion of vaccine and biologics pipelines, growing focus on operational efficiency, increased regulatory emphasis on contamination control. Major trends in the forecast period include increasing adoption of disposable chromatography membranes, rising demand for rapid biomolecule purification, growing use of single-use bioprocessing systems, expansion of high-throughput membrane adsorbers, enhanced focus on contamination risk reduction.

The rising adoption of personalized medicine is expected to drive the growth of the single-use chromatography membrane market in the coming years. Personalized medicine involves tailoring medical treatment to an individual’s genetic, molecular, and clinical characteristics to provide more precise and effective care. Its adoption is increasing due to advances in genomics, which allow therapies to be customized to a patient’s unique genetic profile, enhancing both effectiveness and safety. Single-use chromatography membranes support personalized medicine by enabling faster, flexible, and contamination-free purification of patient-specific biologics, such as customized cell or gene therapies, thereby improving the efficiency and safety of individualized treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six in 2022. The newly approved treatments for 2023 also include seven cancer therapies and three for other diseases and conditions. Thus, the growing prevalence of personalized medicine is fueling the expansion of the single-use chromatography membrane market.

Major companies operating in the single-use chromatography membrane market are concentrating on developing advanced strategies, such as mRNA purification, to improve process efficiency, product yield, and therapeutic quality. mRNA purification involves isolating messenger RNA (mRNA) molecules from a mixture of cellular components or reaction products to obtain high-purity mRNA suitable for therapeutic, vaccine, or research purposes. For example, in December 2024, Repligen Corporation, a US-based life sciences company, introduced AVIPure dsRNA Clear OPUS Columns to streamline and accelerate dsRNA purification for biopharmaceutical production. It provides a rapid, efficient method to remove double-stranded RNA impurities from mRNA therapeutics in just one minute, enhancing drug purity and minimizing unwanted immune responses. This single-use, pre-packed chromatography solution removes the need for heat or solvents, simplifying workflows while supporting scalable production. It plays a crucial role in enabling safer, high-quality mRNA vaccines and therapeutics with cost-effective and seamless integration into biomanufacturing processes.

In February 2023, Biotage AB, a Sweden-based life sciences company, acquired Astrea Bioseparations Ltd. for an undisclosed amount. Through this acquisition, Biotage intends to broaden its chromatography portfolio into the faster-growing bioprocessing sector, strengthen its presence in biologics and advanced therapeutics, and position itself as a global leader in chromatography with a strong pipeline and solid financial standing. Astrea Bioseparations Ltd. is a UK-based biotechnology company focused on single-use chromatography membranes.

Major companies operating in the single-use chromatography membrane market are Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Solventum, Cytiva Life Sciences, W. L. Gore and Associates GORE Membrane Technologies, Sartorius Aktiengesellschaft, AGC Biologics GmbH, Repligen Corporation, GVS Group, i3 Membrane Inc., Cole-Parmer Instrument Company LLC, Restek Corporation, Cobetter Filtration Equipment Company Limited, Membrane Solutions LLC, Izon Science Limited, Sartorius Stedim Biotech S.A., BIA Separations Inc., NATRIX Separations Inc., Purilogics.

North America was the largest region in the single-use chromatography membrane market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use chromatography membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-use chromatography membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the single-use chromatography membrane market by increasing costs of imported polymer materials, membrane fabrication equipment, filtration housings, and precision manufacturing tools. Biopharmaceutical producers in North America and Europe are most affected due to dependence on imported membrane technologies, while Asia-Pacific faces higher costs in membrane export manufacturing. These tariffs are raising consumable pricing and impacting operating expenses. However, they are also driving domestic membrane production, regional supplier diversification, and innovation in cost-optimized single-use purification solutions.

The single-use chromatography membrane market research report is one of a series of new reports that provides single-use chromatography membrane market statistics, including single-use chromatography membrane industry global market size, regional shares, competitors with a single-use chromatography membrane market share, detailed single-use chromatography membrane market segments, market trends and opportunities, and any further data you may need to thrive in the single-use chromatography membrane industry. This single-use chromatography membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A single-use chromatography membrane is a disposable filtration device utilized in bioprocessing and laboratory settings for the quick separation and purification of biomolecules. Unlike conventional reusable chromatography columns, these membranes are intended for one-time use, removing the need for cleaning or sterilization, lowering contamination risk, and enhancing process efficiency.

The main product types of single-use chromatography membranes include membrane adsorbers, capsules or cartridges, filter plates, and others. Membrane adsorbers are porous membranes functionalized with specific ligands that enable selective adsorption and rapid purification of biomolecules in bioprocessing applications. The primary techniques employed include ion exchange, affinity, hydrophobic interaction, and others. These membranes are commonly used in applications such as biopharmaceutical production, vaccine manufacturing, research and development, and others, catering to end-users including pharmaceutical and biotechnology companies, academic and research institutes, and others.

The single-use chromatography membrane market consists of sales of single-use membrane systems, pre-assembled systems, and specialty membrane modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.